Supplement Manufacturing Tech Transfer Checklist: What to Prepare Before Moving Production
Moving an existing supplement product to a new manufacturer is not simply a matter of sending the formula and asking for a new quotation.
The new manufacturer needs enough technical and commercial information to understand what is being transferred, what must remain unchanged, and where differences in raw materials, equipment or process may affect the finished product.
For an established supplement brand, preparing the right technology transfer package before contacting a new OEM manufacturer can make the transfer process more efficient and help identify potential risks before pilot or commercial production.
This guide explains the key information brands should prepare and why each part matters.
Start With a Clear Product Specification and Target-Market Requirements
The first step in a technology transfer is to clearly define both the existing product and the market requirements it must continue to meet.
Before technical transfer begins, the target market should be confirmed. Ingredient status, dosage requirements, product classification, permitted claims, labeling requirements and market-specific documentation can affect raw material selection, product specifications and manufacturing feasibility.
The transfer package should therefore begin with the current product specification, including formula, dosage form, serving information and relevant finished-product specifications. It should also clearly identify the critical product attributes and acceptance criteria that must be maintained after transfer.
Depending on the product, these may include ingredient identity or marker specifications, unit or fill weight, capsule or tablet appearance, disintegration, hardness or friability where applicable, moisture, microbiological limits, color, odor, taste and packaging configuration.
Defining these requirements early gives the new manufacturer a clear basis for feasibility assessment, raw material evaluation, pilot planning and comparability review.
Raw Material Information Is More Important Than Ingredient Names
One of the most common problems during technology transfer is assuming that the same ingredient name means the same raw material.
In practice, raw materials can differ in source, grade, standardization, extract ratio, active marker, carrier content, particle size and other specifications.
This is particularly important for botanical extracts and other specification-sensitive ingredients. Two suppliers may provide materials with the same ingredient name but different extract ratios, standardization levels, active markers, carriers or physical properties.
Raw material equivalence should be considered at two levels.
Specification equivalence covers identity, assay or marker levels, carrier content, contaminants, microbiological requirements and relevant analytical methods.
Manufacturing equivalence considers physical and functional properties that may affect processing, such as particle size, bulk density, moisture, flowability, compressibility, solubility or dispersibility, and sensory characteristics where relevant.
Two raw materials may have similar COA results but still behave differently during blending, filling, compression or other manufacturing steps. The goal is therefore not necessarily to use the exact same supplier, but to determine whether the proposed material is sufficiently comparable for the transferred product and process.
Existing Testing and Batch Data Can Save Transfer Time
Historical quality data gives the new manufacturer a reference for what the product has previously achieved in commercial production.
Useful information may include previous:
- Raw material COAs
- Finished-product COAs
- Third-party testing reports
- Batch testing results
- Stability data
- Manufacturing records
Not every historical document will be required for every project.
However, when the new manufacturer has access to representative data, the technical team can more accurately understand the product’s normal specifications and evaluate whether a proposed raw material or process can achieve comparable results.
This becomes particularly useful when the new factory uses different equipment or sources some raw materials from different suppliers.
Existing stability data can provide useful reference information during transfer, but it does not automatically replace stability assessment at the new manufacturing site. Changes in raw-material sources, manufacturing processes, packaging or other critical product attributes may require a new or bridging stability assessment, depending on the product and target-market requirements.
Provide a Product Sample When Possible
A representative sample can help bridge the gap between written specifications and the actual commercial product.
A sample allows the new manufacturer to review characteristics such as appearance, color, odor, taste, texture and physical format.
For some products, samples from more than one production batch can also help show the normal range of product variation.
However, a sample should be treated as a reference, not as the specification itself.
If a brand wants the transferred product to match a specific commercial standard, the sample should be supported by written specifications and testing requirements.
Previous Manufacturing Information Helps Identify Process Risks
The new manufacturer does not necessarily need to reproduce the original factory’s machine settings.
What matters is understanding the process factors that may affect the finished product.
Depending on the dosage form, relevant information could include blending sequence, fill weight, compression conditions, drying conditions, filling parameters or other critical process information.
For example, a powder that performs well on one production line may behave differently on another if bulk density, flowability or equipment configuration changes.
Previous batch records or process information can therefore help the new manufacturer identify potential manufacturing risks before pilot production.
The goal is process comparability, not simply copying another factory’s equipment settings.
Packaging Should Be Included in the Transfer
Packaging is sometimes treated as a separate purchasing issue, but it can directly affect manufacturing and product stability.
The new manufacturer should understand the existing packaging configuration, such as bottle or pouch type, fill quantity, closure, desiccant, label dimensions and other relevant components.
Packaging transfer should also consider equipment compatibility, including bottle neck and closure compatibility, label dimensions and labeler compatibility, blister tooling, sachet or stick-pack film width, rollstock specifications, coding position and carton dimensions where applicable.
These details can affect line compatibility, tooling requirements, packaging setup, material availability and lead time, so they should be reviewed before commercial production.
If packaging needs to change, the brand should understand the potential impact on artwork, packaging MOQ, lead time, finished cost and, where relevant, product stability.
Confirm the Target Market and Regulatory Requirements
Technology transfer is also an appropriate point to reconfirm the target market.
Ingredient status, dosage, product classification, labeling and claims requirements can vary between markets. A product that has already been manufactured successfully for one market is not automatically suitable for another.
For this reason, the target country or market should be included in the transfer information provided to the manufacturer.
A preliminary target-market and regulatory review can identify potential issues before the transferred specification and packaging are finalized.
This is usually more efficient than completing the manufacturing transfer first and discovering a market-specific requirement afterward.
Where applicable, the transfer package should also include existing regulatory or market-entry documents, such as facility registration information, product notifications, or health certificates required by the target market or for cross-border shipment.
Clarify Transfer Rights and Approval Responsibilities
Technical information should only be transferred when the brand has the appropriate rights to provide it.
This matters when the product involves proprietary formulas, branded ingredients, licensed technologies or supplier-controlled specifications.
Before sensitive formula, supplier or process information is transferred, the brand and manufacturer should also agree on appropriate confidentiality arrangements and secure technical-document exchange, including an NDA or confidentiality agreement where required.
This helps protect proprietary product information while allowing the new manufacturer to conduct the technical and manufacturing assessment needed for the transfer.
The brand and new manufacturer should also clarify which stages require brand approval. Depending on the project, this may include raw materials, prototypes, pilot batches, finished-product specifications or packaging.
Clear responsibilities help avoid a common problem in technology transfer: assuming that technical approval and commercial approval are the same thing.
What Should Be Included in a Transfer Package?
A practical transfer package does not need to contain every document ever generated for the product. It should contain the information necessary for the new manufacturer to understand the product and evaluate the transfer.
Information
Typical Content
Product
Formula, dosage, dosage form, finished specifications and critical acceptance criteria
Raw Materials
Critical specifications, supplier information and COAs
Quality
Testing requirements, previous results and stability data
Manufacturing
Available process and batch information
Sample
Representative commercial product
Packaging
Existing configuration, specifications and relevant compatibility information
Market / Regulatory
Target country, labeling requirements, product classification and applicable regulatory or market-entry documents
Approvals
Required review and approval points for raw materials, prototypes, pilot batches, specifications, packaging and regulatory documentation
Transfer Rights / Confidentiality
Ownership, confidentiality, NDA requirements and secure technical-document exchange
The exact scope depends on the product and the completeness of the existing documentation.
When Is a Pilot Batch Needed?
A pilot batch is not automatically required for every transfer.
If the formula, raw materials, equipment and manufacturing process are highly comparable, the transfer may be relatively straightforward.
A pilot becomes more valuable when there are meaningful differences—for example, a new raw material supplier, different equipment, a different manufacturing process or a technically sensitive dosage form.
The pilot gives the manufacturer an opportunity to confirm process performance and evaluate key product characteristics before commercial production.
Where appropriate, pilot results can then support a comparability assessment and brand approval before the first commercial batch.
Think Beyond the First Commercial Batch
A technology transfer should not end when the first batch is successfully produced.
The brand and manufacturer should also agree on how future changes will be controlled.
Supplier changes, raw material specification changes, packaging changes, process adjustments or regulatory-status changes can all affect a transferred product.
A defined change-control process helps ensure that significant changes are assessed and communicated before they affect the product.
This is particularly important for established products where consistency across future batches is as important as successfully completing the initial transfer.
For higher-risk transfers, the first commercial batches may also require enhanced review of agreed critical product attributes before the product moves into routine supply. This provides additional confirmation that the transferred process remains within the agreed acceptance criteria under commercial manufacturing conditions.
The level of post-commercial review should be based on the product, transfer risks and applicable quality requirements rather than a fixed number of batches.
A Practical Technology Transfer Workflow
A typical transfer may follow:
Existing Product → Transfer Rights / NDA → Transfer Package Review → Target-Market Pre-Screen → Manufacturing Feasibility → Raw Material Equivalence → Process Review → Pilot / Comparability → Brand Approval → Final Packaging / Documentation Review → Commercial Production → Change Control / Enhanced Post-Commercial Review
Not every project needs the same level of work.
A simple stock product with complete documentation may require a relatively straightforward review, while a technically complex product or significant manufacturing change may require additional testing, pilot production, comparability assessment or stability bridging.
The appropriate transfer scope should therefore be based on the actual product, documentation, manufacturing changes and target-market requirements involved.
FAQ
Q1. What information should I prepare before transferring a supplement to a new manufacturer?
Prepare the current formula, product specifications, raw material information, testing records, product samples, packaging information and target-market requirements.
Q2. Do I need to provide the original manufacturer's raw material suppliers?
Not always, but supplier and specification information can be important for critical ingredients.
Q3. Do I need to provide previous COAs and testing reports?
Where available, yes.
Q4. Is a pilot batch always required when changing manufacturers?
No. The need depends on the transfer scope and product complexity.
Q5. What if my existing transfer documentation is incomplete?
The transfer can still be evaluated, but additional information or testing may be required.
Next Step
Before moving an existing supplement product to a new manufacturer, prepare the available formula, specifications, raw material information, quality records, product samples and packaging information.
A structured review can then determine what additional testing, pilot work or technical evaluation is needed before commercial production.
Request a Manufacturing Feasibility Review
Share this page to